nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—Budesonide—ulcerative colitis	0.128	0.256	CbGbCtD
Alfuzosin—CYP3A4—Methylprednisolone—ulcerative colitis	0.0572	0.115	CbGbCtD
Alfuzosin—CYP3A4—Nicotine—ulcerative colitis	0.0558	0.112	CbGbCtD
Alfuzosin—CYP3A4—Cholecalciferol—ulcerative colitis	0.05	0.1	CbGbCtD
Alfuzosin—CYP3A4—Triamcinolone—ulcerative colitis	0.0434	0.0868	CbGbCtD
Alfuzosin—CYP3A4—Betamethasone—ulcerative colitis	0.0372	0.0745	CbGbCtD
Alfuzosin—CYP3A4—Prednisolone—ulcerative colitis	0.0367	0.0735	CbGbCtD
Alfuzosin—CYP3A4—Hydrocortisone—ulcerative colitis	0.0348	0.0697	CbGbCtD
Alfuzosin—CYP3A4—Prednisone—ulcerative colitis	0.0347	0.0694	CbGbCtD
Alfuzosin—CYP3A4—Dexamethasone—ulcerative colitis	0.0216	0.0433	CbGbCtD
Alfuzosin—Terazosin—ABCB1—ulcerative colitis	0.00282	0.412	CrCbGaD
Alfuzosin—Doxazosin—ABCB1—ulcerative colitis	0.0021	0.306	CrCbGaD
Alfuzosin—Prazosin—ABCB1—ulcerative colitis	0.00193	0.282	CrCbGaD
Alfuzosin—Diarrhoea—Budesonide—ulcerative colitis	0.000597	0.00132	CcSEcCtD
Alfuzosin—Ill-defined disorder—Prednisolone—ulcerative colitis	0.000587	0.00129	CcSEcCtD
Alfuzosin—Feeling abnormal—Mesalazine—ulcerative colitis	0.000585	0.00129	CcSEcCtD
Alfuzosin—Mental disorder—Methylprednisolone—ulcerative colitis	0.000585	0.00129	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.00058	0.00128	CcSEcCtD
Alfuzosin—Angioedema—Prednisolone—ulcerative colitis	0.000578	0.00128	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Prednisone—ulcerative colitis	0.000577	0.00127	CcSEcCtD
Alfuzosin—Dizziness—Budesonide—ulcerative colitis	0.000577	0.00127	CcSEcCtD
Alfuzosin—Ill-defined disorder—Hydrocortisone—ulcerative colitis	0.000574	0.00126	CcSEcCtD
Alfuzosin—Malaise—Prednisolone—ulcerative colitis	0.000571	0.00126	CcSEcCtD
Alfuzosin—Vertigo—Prednisolone—ulcerative colitis	0.000569	0.00125	CcSEcCtD
Alfuzosin—Syncope—Prednisolone—ulcerative colitis	0.000568	0.00125	CcSEcCtD
Alfuzosin—Eye disorder—Betamethasone—ulcerative colitis	0.000567	0.00125	CcSEcCtD
Alfuzosin—Eye disorder—Dexamethasone—ulcerative colitis	0.000567	0.00125	CcSEcCtD
Alfuzosin—Angioedema—Hydrocortisone—ulcerative colitis	0.000565	0.00125	CcSEcCtD
Alfuzosin—Urticaria—Mesalazine—ulcerative colitis	0.000564	0.00124	CcSEcCtD
Alfuzosin—Back pain—Triamcinolone—ulcerative colitis	0.000563	0.00124	CcSEcCtD
Alfuzosin—Abdominal pain—Mesalazine—ulcerative colitis	0.000561	0.00124	CcSEcCtD
Alfuzosin—Malaise—Hydrocortisone—ulcerative colitis	0.000558	0.00123	CcSEcCtD
Alfuzosin—Loss of consciousness—Prednisolone—ulcerative colitis	0.000556	0.00123	CcSEcCtD
Alfuzosin—Vertigo—Hydrocortisone—ulcerative colitis	0.000555	0.00122	CcSEcCtD
Alfuzosin—Vomiting—Budesonide—ulcerative colitis	0.000555	0.00122	CcSEcCtD
Alfuzosin—Syncope—Hydrocortisone—ulcerative colitis	0.000554	0.00122	CcSEcCtD
Alfuzosin—Angiopathy—Dexamethasone—ulcerative colitis	0.000551	0.00121	CcSEcCtD
Alfuzosin—Angiopathy—Betamethasone—ulcerative colitis	0.000551	0.00121	CcSEcCtD
Alfuzosin—Rash—Budesonide—ulcerative colitis	0.00055	0.00121	CcSEcCtD
Alfuzosin—Dermatitis—Budesonide—ulcerative colitis	0.00055	0.00121	CcSEcCtD
Alfuzosin—Headache—Budesonide—ulcerative colitis	0.000547	0.00121	CcSEcCtD
Alfuzosin—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000543	0.0012	CcSEcCtD
Alfuzosin—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.00054	0.00119	CcSEcCtD
Alfuzosin—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.000539	0.00119	CcSEcCtD
Alfuzosin—Diarrhoea—Azathioprine—ulcerative colitis	0.000533	0.00118	CcSEcCtD
Alfuzosin—Discomfort—Prednisolone—ulcerative colitis	0.000533	0.00117	CcSEcCtD
Alfuzosin—Angioedema—Triamcinolone—ulcerative colitis	0.000532	0.00117	CcSEcCtD
Alfuzosin—Angioedema—Methylprednisolone—ulcerative colitis	0.000531	0.00117	CcSEcCtD
Alfuzosin—Malaise—Triamcinolone—ulcerative colitis	0.000525	0.00116	CcSEcCtD
Alfuzosin—Malaise—Methylprednisolone—ulcerative colitis	0.000524	0.00115	CcSEcCtD
Alfuzosin—Vertigo—Triamcinolone—ulcerative colitis	0.000523	0.00115	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000523	0.00115	CcSEcCtD
Alfuzosin—Syncope—Triamcinolone—ulcerative colitis	0.000522	0.00115	CcSEcCtD
Alfuzosin—Vertigo—Methylprednisolone—ulcerative colitis	0.000522	0.00115	CcSEcCtD
Alfuzosin—Syncope—Methylprednisolone—ulcerative colitis	0.000521	0.00115	CcSEcCtD
Alfuzosin—Discomfort—Hydrocortisone—ulcerative colitis	0.00052	0.00115	CcSEcCtD
Alfuzosin—Connective tissue disorder—Prednisone—ulcerative colitis	0.000519	0.00114	CcSEcCtD
Alfuzosin—Nausea—Budesonide—ulcerative colitis	0.000518	0.00114	CcSEcCtD
Alfuzosin—Oedema—Prednisolone—ulcerative colitis	0.000517	0.00114	CcSEcCtD
Alfuzosin—Dizziness—Azathioprine—ulcerative colitis	0.000515	0.00114	CcSEcCtD
Alfuzosin—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000512	0.00113	CcSEcCtD
Alfuzosin—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000511	0.00113	CcSEcCtD
Alfuzosin—Asthenia—Mesalazine—ulcerative colitis	0.000509	0.00112	CcSEcCtD
Alfuzosin—Shock—Prednisolone—ulcerative colitis	0.000508	0.00112	CcSEcCtD
Alfuzosin—Oedema—Hydrocortisone—ulcerative colitis	0.000505	0.00111	CcSEcCtD
Alfuzosin—Tachycardia—Prednisolone—ulcerative colitis	0.000504	0.00111	CcSEcCtD
Alfuzosin—Pruritus—Mesalazine—ulcerative colitis	0.000502	0.00111	CcSEcCtD
Alfuzosin—Infection—Hydrocortisone—ulcerative colitis	0.000501	0.00111	CcSEcCtD
Alfuzosin—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000499	0.0011	CcSEcCtD
Alfuzosin—Shock—Hydrocortisone—ulcerative colitis	0.000496	0.00109	CcSEcCtD
Alfuzosin—Vomiting—Azathioprine—ulcerative colitis	0.000495	0.00109	CcSEcCtD
Alfuzosin—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000495	0.00109	CcSEcCtD
Alfuzosin—Arthralgia—Methylprednisolone—ulcerative colitis	0.000495	0.00109	CcSEcCtD
Alfuzosin—Eye disorder—Prednisone—ulcerative colitis	0.000494	0.00109	CcSEcCtD
Alfuzosin—Tachycardia—Hydrocortisone—ulcerative colitis	0.000492	0.00109	CcSEcCtD
Alfuzosin—Rash—Azathioprine—ulcerative colitis	0.000491	0.00108	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000491	0.00108	CcSEcCtD
Alfuzosin—Dermatitis—Azathioprine—ulcerative colitis	0.000491	0.00108	CcSEcCtD
Alfuzosin—Flushing—Prednisone—ulcerative colitis	0.00049	0.00108	CcSEcCtD
Alfuzosin—Skin disorder—Hydrocortisone—ulcerative colitis	0.00049	0.00108	CcSEcCtD
Alfuzosin—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.00049	0.00108	CcSEcCtD
Alfuzosin—Ill-defined disorder—Betamethasone—ulcerative colitis	0.00049	0.00108	CcSEcCtD
Alfuzosin—Discomfort—Triamcinolone—ulcerative colitis	0.00049	0.00108	CcSEcCtD
Alfuzosin—Discomfort—Methylprednisolone—ulcerative colitis	0.000489	0.00108	CcSEcCtD
Alfuzosin—Headache—Azathioprine—ulcerative colitis	0.000488	0.00108	CcSEcCtD
Alfuzosin—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000488	0.00108	CcSEcCtD
Alfuzosin—Diarrhoea—Mesalazine—ulcerative colitis	0.000486	0.00107	CcSEcCtD
Alfuzosin—Dry mouth—Triamcinolone—ulcerative colitis	0.000485	0.00107	CcSEcCtD
Alfuzosin—Angioedema—Betamethasone—ulcerative colitis	0.000483	0.00106	CcSEcCtD
Alfuzosin—Angioedema—Dexamethasone—ulcerative colitis	0.000483	0.00106	CcSEcCtD
Alfuzosin—Angiopathy—Prednisone—ulcerative colitis	0.000479	0.00106	CcSEcCtD
Alfuzosin—Malaise—Betamethasone—ulcerative colitis	0.000476	0.00105	CcSEcCtD
Alfuzosin—Malaise—Dexamethasone—ulcerative colitis	0.000476	0.00105	CcSEcCtD
Alfuzosin—Oedema—Triamcinolone—ulcerative colitis	0.000475	0.00105	CcSEcCtD
Alfuzosin—Vertigo—Betamethasone—ulcerative colitis	0.000475	0.00105	CcSEcCtD
Alfuzosin—Vertigo—Dexamethasone—ulcerative colitis	0.000475	0.00105	CcSEcCtD
Alfuzosin—Syncope—Betamethasone—ulcerative colitis	0.000474	0.00104	CcSEcCtD
Alfuzosin—Syncope—Dexamethasone—ulcerative colitis	0.000474	0.00104	CcSEcCtD
Alfuzosin—Infection—Triamcinolone—ulcerative colitis	0.000472	0.00104	CcSEcCtD
Alfuzosin—Hypotension—Hydrocortisone—ulcerative colitis	0.000472	0.00104	CcSEcCtD
Alfuzosin—Infection—Methylprednisolone—ulcerative colitis	0.000471	0.00104	CcSEcCtD
Alfuzosin—Dizziness—Mesalazine—ulcerative colitis	0.000469	0.00103	CcSEcCtD
Alfuzosin—Shock—Triamcinolone—ulcerative colitis	0.000467	0.00103	CcSEcCtD
Alfuzosin—Shock—Methylprednisolone—ulcerative colitis	0.000466	0.00103	CcSEcCtD
Alfuzosin—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000465	0.00102	CcSEcCtD
Alfuzosin—Loss of consciousness—Betamethasone—ulcerative colitis	0.000464	0.00102	CcSEcCtD
Alfuzosin—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000464	0.00102	CcSEcCtD
Alfuzosin—Tachycardia—Triamcinolone—ulcerative colitis	0.000464	0.00102	CcSEcCtD
Alfuzosin—Mental disorder—Prednisone—ulcerative colitis	0.000463	0.00102	CcSEcCtD
Alfuzosin—Nausea—Azathioprine—ulcerative colitis	0.000463	0.00102	CcSEcCtD
Alfuzosin—Tachycardia—Methylprednisolone—ulcerative colitis	0.000463	0.00102	CcSEcCtD
Alfuzosin—Skin disorder—Methylprednisolone—ulcerative colitis	0.00046	0.00102	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.00046	0.00101	CcSEcCtD
Alfuzosin—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000459	0.00101	CcSEcCtD
Alfuzosin—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000458	0.00101	CcSEcCtD
Alfuzosin—Vomiting—Mesalazine—ulcerative colitis	0.000451	0.000995	CcSEcCtD
Alfuzosin—Rash—Mesalazine—ulcerative colitis	0.000447	0.000986	CcSEcCtD
Alfuzosin—Dermatitis—Mesalazine—ulcerative colitis	0.000447	0.000985	CcSEcCtD
Alfuzosin—Headache—Mesalazine—ulcerative colitis	0.000445	0.00098	CcSEcCtD
Alfuzosin—Discomfort—Betamethasone—ulcerative colitis	0.000444	0.00098	CcSEcCtD
Alfuzosin—Discomfort—Dexamethasone—ulcerative colitis	0.000444	0.00098	CcSEcCtD
Alfuzosin—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000444	0.000979	CcSEcCtD
Alfuzosin—Hypotension—Methylprednisolone—ulcerative colitis	0.000443	0.000977	CcSEcCtD
Alfuzosin—Pain—Prednisolone—ulcerative colitis	0.000442	0.000974	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000436	0.00096	CcSEcCtD
Alfuzosin—Fatigue—Hydrocortisone—ulcerative colitis	0.000435	0.000959	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000433	0.000954	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000432	0.000952	CcSEcCtD
Alfuzosin—Pain—Hydrocortisone—ulcerative colitis	0.000432	0.000951	CcSEcCtD
Alfuzosin—Oedema—Dexamethasone—ulcerative colitis	0.000431	0.00095	CcSEcCtD
Alfuzosin—Oedema—Betamethasone—ulcerative colitis	0.000431	0.00095	CcSEcCtD
Alfuzosin—Infection—Betamethasone—ulcerative colitis	0.000428	0.000944	CcSEcCtD
Alfuzosin—Infection—Dexamethasone—ulcerative colitis	0.000428	0.000944	CcSEcCtD
Alfuzosin—Ill-defined disorder—Prednisone—ulcerative colitis	0.000427	0.000941	CcSEcCtD
Alfuzosin—Feeling abnormal—Prednisolone—ulcerative colitis	0.000426	0.000939	CcSEcCtD
Alfuzosin—Shock—Dexamethasone—ulcerative colitis	0.000424	0.000935	CcSEcCtD
Alfuzosin—Shock—Betamethasone—ulcerative colitis	0.000424	0.000935	CcSEcCtD
Alfuzosin—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000423	0.000932	CcSEcCtD
Alfuzosin—Nervous system disorder—Betamethasone—ulcerative colitis	0.000423	0.000932	CcSEcCtD
Alfuzosin—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000422	0.000931	CcSEcCtD
Alfuzosin—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000422	0.000931	CcSEcCtD
Alfuzosin—Nausea—Mesalazine—ulcerative colitis	0.000421	0.000929	CcSEcCtD
Alfuzosin—Tachycardia—Dexamethasone—ulcerative colitis	0.000421	0.000928	CcSEcCtD
Alfuzosin—Tachycardia—Betamethasone—ulcerative colitis	0.000421	0.000928	CcSEcCtD
Alfuzosin—Angioedema—Prednisone—ulcerative colitis	0.00042	0.000927	CcSEcCtD
Alfuzosin—Dyspepsia—Triamcinolone—ulcerative colitis	0.000418	0.000922	CcSEcCtD
Alfuzosin—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000417	0.00092	CcSEcCtD
Alfuzosin—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000417	0.000919	CcSEcCtD
Alfuzosin—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000417	0.000919	CcSEcCtD
Alfuzosin—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000416	0.000917	CcSEcCtD
Alfuzosin—Malaise—Prednisone—ulcerative colitis	0.000415	0.000915	CcSEcCtD
Alfuzosin—Vertigo—Prednisone—ulcerative colitis	0.000413	0.000911	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000413	0.00091	CcSEcCtD
Alfuzosin—Syncope—Prednisone—ulcerative colitis	0.000413	0.000909	CcSEcCtD
Alfuzosin—Urticaria—Prednisolone—ulcerative colitis	0.00041	0.000905	CcSEcCtD
Alfuzosin—Fatigue—Triamcinolone—ulcerative colitis	0.00041	0.000903	CcSEcCtD
Alfuzosin—Fatigue—Methylprednisolone—ulcerative colitis	0.000409	0.000901	CcSEcCtD
Alfuzosin—Pain—Triamcinolone—ulcerative colitis	0.000406	0.000896	CcSEcCtD
Alfuzosin—Loss of consciousness—Prednisone—ulcerative colitis	0.000404	0.000891	CcSEcCtD
Alfuzosin—Hypotension—Betamethasone—ulcerative colitis	0.000403	0.000888	CcSEcCtD
Alfuzosin—Hypotension—Dexamethasone—ulcerative colitis	0.000403	0.000888	CcSEcCtD
Alfuzosin—Urticaria—Hydrocortisone—ulcerative colitis	0.000401	0.000884	CcSEcCtD
Alfuzosin—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000399	0.000879	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000393	0.000866	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000393	0.000866	CcSEcCtD
Alfuzosin—Arthralgia—Prednisone—ulcerative colitis	0.000392	0.000863	CcSEcCtD
Alfuzosin—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000392	0.000863	CcSEcCtD
Alfuzosin—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000391	0.000861	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000389	0.000857	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000388	0.000855	CcSEcCtD
Alfuzosin—Discomfort—Prednisone—ulcerative colitis	0.000387	0.000853	CcSEcCtD
Alfuzosin—Dyspepsia—Betamethasone—ulcerative colitis	0.000379	0.000837	CcSEcCtD
Alfuzosin—Dyspepsia—Dexamethasone—ulcerative colitis	0.000379	0.000837	CcSEcCtD
Alfuzosin—Urticaria—Triamcinolone—ulcerative colitis	0.000377	0.000832	CcSEcCtD
Alfuzosin—Urticaria—Methylprednisolone—ulcerative colitis	0.000377	0.00083	CcSEcCtD
Alfuzosin—Oedema—Prednisone—ulcerative colitis	0.000375	0.000828	CcSEcCtD
Alfuzosin—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000375	0.000826	CcSEcCtD
Alfuzosin—Infection—Prednisone—ulcerative colitis	0.000373	0.000822	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000372	0.000821	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000372	0.000821	CcSEcCtD
Alfuzosin—Fatigue—Dexamethasone—ulcerative colitis	0.000372	0.000819	CcSEcCtD
Alfuzosin—Fatigue—Betamethasone—ulcerative colitis	0.000372	0.000819	CcSEcCtD
Alfuzosin—Shock—Prednisone—ulcerative colitis	0.000369	0.000814	CcSEcCtD
Alfuzosin—Pain—Dexamethasone—ulcerative colitis	0.000369	0.000813	CcSEcCtD
Alfuzosin—Pain—Betamethasone—ulcerative colitis	0.000369	0.000813	CcSEcCtD
Alfuzosin—Nervous system disorder—Prednisone—ulcerative colitis	0.000368	0.000812	CcSEcCtD
Alfuzosin—Tachycardia—Prednisone—ulcerative colitis	0.000366	0.000808	CcSEcCtD
Alfuzosin—Skin disorder—Prednisone—ulcerative colitis	0.000365	0.000804	CcSEcCtD
Alfuzosin—Hyperhidrosis—Prednisone—ulcerative colitis	0.000363	0.0008	CcSEcCtD
Alfuzosin—Asthenia—Hydrocortisone—ulcerative colitis	0.000362	0.000798	CcSEcCtD
Alfuzosin—Pruritus—Hydrocortisone—ulcerative colitis	0.000357	0.000787	CcSEcCtD
Alfuzosin—Feeling abnormal—Betamethasone—ulcerative colitis	0.000355	0.000783	CcSEcCtD
Alfuzosin—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000355	0.000783	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000353	0.000777	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000353	0.000777	CcSEcCtD
Alfuzosin—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000345	0.000761	CcSEcCtD
Alfuzosin—Urticaria—Betamethasone—ulcerative colitis	0.000342	0.000755	CcSEcCtD
Alfuzosin—Urticaria—Dexamethasone—ulcerative colitis	0.000342	0.000755	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000342	0.000754	CcSEcCtD
Alfuzosin—Dizziness—Prednisolone—ulcerative colitis	0.000342	0.000753	CcSEcCtD
Alfuzosin—Asthenia—Triamcinolone—ulcerative colitis	0.000341	0.000752	CcSEcCtD
Alfuzosin—Abdominal pain—Betamethasone—ulcerative colitis	0.000341	0.000751	CcSEcCtD
Alfuzosin—Abdominal pain—Dexamethasone—ulcerative colitis	0.000341	0.000751	CcSEcCtD
Alfuzosin—Asthenia—Methylprednisolone—ulcerative colitis	0.00034	0.00075	CcSEcCtD
Alfuzosin—Pruritus—Triamcinolone—ulcerative colitis	0.000336	0.000741	CcSEcCtD
Alfuzosin—Pruritus—Methylprednisolone—ulcerative colitis	0.000335	0.000739	CcSEcCtD
Alfuzosin—Dizziness—Hydrocortisone—ulcerative colitis	0.000334	0.000736	CcSEcCtD
Alfuzosin—Dyspepsia—Prednisone—ulcerative colitis	0.00033	0.000729	CcSEcCtD
Alfuzosin—Rash—Prednisolone—ulcerative colitis	0.000326	0.000718	CcSEcCtD
Alfuzosin—Dermatitis—Prednisolone—ulcerative colitis	0.000325	0.000718	CcSEcCtD
Alfuzosin—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000324	0.000715	CcSEcCtD
Alfuzosin—Fatigue—Prednisone—ulcerative colitis	0.000324	0.000714	CcSEcCtD
Alfuzosin—Headache—Prednisolone—ulcerative colitis	0.000324	0.000714	CcSEcCtD
Alfuzosin—Constipation—Prednisone—ulcerative colitis	0.000321	0.000708	CcSEcCtD
Alfuzosin—Vomiting—Hydrocortisone—ulcerative colitis	0.000321	0.000707	CcSEcCtD
Alfuzosin—Rash—Hydrocortisone—ulcerative colitis	0.000318	0.000701	CcSEcCtD
Alfuzosin—Dermatitis—Hydrocortisone—ulcerative colitis	0.000318	0.000701	CcSEcCtD
Alfuzosin—Headache—Hydrocortisone—ulcerative colitis	0.000316	0.000697	CcSEcCtD
Alfuzosin—Dizziness—Triamcinolone—ulcerative colitis	0.000314	0.000693	CcSEcCtD
Alfuzosin—Dizziness—Methylprednisolone—ulcerative colitis	0.000313	0.000691	CcSEcCtD
Alfuzosin—Feeling abnormal—Prednisone—ulcerative colitis	0.000309	0.000682	CcSEcCtD
Alfuzosin—Asthenia—Dexamethasone—ulcerative colitis	0.000309	0.000682	CcSEcCtD
Alfuzosin—Asthenia—Betamethasone—ulcerative colitis	0.000309	0.000682	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000307	0.000677	CcSEcCtD
Alfuzosin—Nausea—Prednisolone—ulcerative colitis	0.000307	0.000677	CcSEcCtD
Alfuzosin—Pruritus—Dexamethasone—ulcerative colitis	0.000305	0.000672	CcSEcCtD
Alfuzosin—Pruritus—Betamethasone—ulcerative colitis	0.000305	0.000672	CcSEcCtD
Alfuzosin—Vomiting—Triamcinolone—ulcerative colitis	0.000302	0.000666	CcSEcCtD
Alfuzosin—Vomiting—Methylprednisolone—ulcerative colitis	0.000301	0.000665	CcSEcCtD
Alfuzosin—Nausea—Hydrocortisone—ulcerative colitis	0.0003	0.000661	CcSEcCtD
Alfuzosin—Rash—Triamcinolone—ulcerative colitis	0.0003	0.00066	CcSEcCtD
Alfuzosin—Dermatitis—Triamcinolone—ulcerative colitis	0.000299	0.00066	CcSEcCtD
Alfuzosin—Rash—Methylprednisolone—ulcerative colitis	0.000299	0.000659	CcSEcCtD
Alfuzosin—Dermatitis—Methylprednisolone—ulcerative colitis	0.000299	0.000658	CcSEcCtD
Alfuzosin—Urticaria—Prednisone—ulcerative colitis	0.000298	0.000658	CcSEcCtD
Alfuzosin—Headache—Triamcinolone—ulcerative colitis	0.000298	0.000656	CcSEcCtD
Alfuzosin—Headache—Methylprednisolone—ulcerative colitis	0.000297	0.000655	CcSEcCtD
Alfuzosin—Abdominal pain—Prednisone—ulcerative colitis	0.000297	0.000654	CcSEcCtD
Alfuzosin—Diarrhoea—Dexamethasone—ulcerative colitis	0.000295	0.00065	CcSEcCtD
Alfuzosin—Diarrhoea—Betamethasone—ulcerative colitis	0.000295	0.00065	CcSEcCtD
Alfuzosin—Dizziness—Dexamethasone—ulcerative colitis	0.000285	0.000628	CcSEcCtD
Alfuzosin—Dizziness—Betamethasone—ulcerative colitis	0.000285	0.000628	CcSEcCtD
Alfuzosin—Nausea—Triamcinolone—ulcerative colitis	0.000282	0.000622	CcSEcCtD
Alfuzosin—Nausea—Methylprednisolone—ulcerative colitis	0.000282	0.000621	CcSEcCtD
Alfuzosin—Vomiting—Betamethasone—ulcerative colitis	0.000274	0.000604	CcSEcCtD
Alfuzosin—Vomiting—Dexamethasone—ulcerative colitis	0.000274	0.000604	CcSEcCtD
Alfuzosin—Rash—Dexamethasone—ulcerative colitis	0.000272	0.000599	CcSEcCtD
Alfuzosin—Rash—Betamethasone—ulcerative colitis	0.000272	0.000599	CcSEcCtD
Alfuzosin—Dermatitis—Dexamethasone—ulcerative colitis	0.000272	0.000599	CcSEcCtD
Alfuzosin—Dermatitis—Betamethasone—ulcerative colitis	0.000272	0.000599	CcSEcCtD
Alfuzosin—Headache—Betamethasone—ulcerative colitis	0.00027	0.000595	CcSEcCtD
Alfuzosin—Headache—Dexamethasone—ulcerative colitis	0.00027	0.000595	CcSEcCtD
Alfuzosin—Asthenia—Prednisone—ulcerative colitis	0.000269	0.000594	CcSEcCtD
Alfuzosin—Pruritus—Prednisone—ulcerative colitis	0.000266	0.000586	CcSEcCtD
Alfuzosin—Diarrhoea—Prednisone—ulcerative colitis	0.000257	0.000566	CcSEcCtD
Alfuzosin—Nausea—Betamethasone—ulcerative colitis	0.000256	0.000565	CcSEcCtD
Alfuzosin—Nausea—Dexamethasone—ulcerative colitis	0.000256	0.000565	CcSEcCtD
Alfuzosin—Dizziness—Prednisone—ulcerative colitis	0.000248	0.000547	CcSEcCtD
Alfuzosin—Vomiting—Prednisone—ulcerative colitis	0.000239	0.000526	CcSEcCtD
Alfuzosin—Rash—Prednisone—ulcerative colitis	0.000237	0.000522	CcSEcCtD
Alfuzosin—Dermatitis—Prednisone—ulcerative colitis	0.000237	0.000521	CcSEcCtD
Alfuzosin—Headache—Prednisone—ulcerative colitis	0.000235	0.000519	CcSEcCtD
Alfuzosin—Nausea—Prednisone—ulcerative colitis	0.000223	0.000492	CcSEcCtD
Alfuzosin—ADRA1B—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	0.000204	0.00513	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000204	0.00511	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000203	0.0051	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000196	0.00493	CbGpPWpGaD
Alfuzosin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000191	0.0048	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000189	0.00476	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000185	0.00465	CbGpPWpGaD
Alfuzosin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000182	0.00457	CbGpPWpGaD
Alfuzosin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000182	0.00456	CbGpPWpGaD
Alfuzosin—ADRA1A—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	0.000181	0.00455	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—CXCR1—ulcerative colitis	0.00018	0.00452	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000179	0.0045	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000179	0.00449	CbGpPWpGaD
Alfuzosin—ADRA1D—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	0.000178	0.00448	CbGpPWpGaD
Alfuzosin—ADRA1B—LPA receptor mediated events—RELA—ulcerative colitis	0.000176	0.00441	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000176	0.00441	CbGpPWpGaD
Alfuzosin—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	0.000175	0.00438	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000174	0.00438	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000174	0.00437	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000172	0.00433	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000169	0.00423	CbGpPWpGaD
Alfuzosin—ADRA1B—LPA receptor mediated events—CXCL8—ulcerative colitis	0.000166	0.00416	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000159	0.004	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—CCL20—ulcerative colitis	0.000158	0.00397	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000157	0.00395	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000156	0.00392	CbGpPWpGaD
Alfuzosin—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	0.000155	0.00389	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000154	0.00386	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000153	0.00385	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000153	0.00384	CbGpPWpGaD
Alfuzosin—KCNH2—Neuronal System—ADCY5—ulcerative colitis	0.00015	0.00377	CbGpPWpGaD
Alfuzosin—ADRA1B—LPA receptor mediated events—MMP9—ulcerative colitis	0.00015	0.00376	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00015	0.00376	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—CXCR1—ulcerative colitis	0.00015	0.00375	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000148	0.00373	CbGpPWpGaD
Alfuzosin—ADRA1B—LPA receptor mediated events—NFKB1—ulcerative colitis	0.000148	0.00372	CbGpPWpGaD
Alfuzosin—ADRA1B—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	0.000148	0.00372	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000144	0.00363	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—CXCR2—ulcerative colitis	0.000141	0.00354	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.00014	0.00352	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.00014	0.00351	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000136	0.00343	CbGpPWpGaD
Alfuzosin—KCNH2—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	0.000136	0.00341	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000136	0.0034	CbGpPWpGaD
Alfuzosin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000134	0.00336	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—CXCR1—ulcerative colitis	0.000133	0.00333	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—CCR6—ulcerative colitis	0.000133	0.00333	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000132	0.00331	CbGpPWpGaD
Alfuzosin—ADRA1A—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	0.000132	0.0033	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—CCL20—ulcerative colitis	0.000131	0.00329	CbGpPWpGaD
Alfuzosin—KCNH2—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	0.00013	0.00328	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000128	0.00322	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000127	0.00319	CbGpPWpGaD
Alfuzosin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000127	0.00318	CbGpPWpGaD
Alfuzosin—KCNH2—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	0.000122	0.00306	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—CXCR2—ulcerative colitis	0.000117	0.00294	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—PTGER4—ulcerative colitis	0.000117	0.00293	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—CCL20—ulcerative colitis	0.000117	0.00293	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000116	0.00292	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000116	0.00291	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000113	0.00284	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000112	0.00282	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—CCR6—ulcerative colitis	0.00011	0.00276	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—GHRL—ulcerative colitis	0.000107	0.00268	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—CXCR2—ulcerative colitis	0.000104	0.00261	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000103	0.0026	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000102	0.00256	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	9.99e-05	0.00251	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—CCR6—ulcerative colitis	9.77e-05	0.00245	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—PTGER4—ulcerative colitis	9.68e-05	0.00243	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	9.64e-05	0.00242	CbGpPWpGaD
Alfuzosin—ADRA1B—AMPK Signaling—TP53—ulcerative colitis	9.58e-05	0.0024	CbGpPWpGaD
Alfuzosin—KCNH2—SIDS Susceptibility Pathways—TNF—ulcerative colitis	9.47e-05	0.00238	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CXCR1—ulcerative colitis	9.24e-05	0.00232	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—CCL20—ulcerative colitis	8.94e-05	0.00224	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—GHRL—ulcerative colitis	8.87e-05	0.00223	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—ADRB2—ulcerative colitis	8.84e-05	0.00222	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—PTGER4—ulcerative colitis	8.6e-05	0.00216	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	8.56e-05	0.00215	CbGpPWpGaD
Alfuzosin—ADRA1A—AMPK Signaling—TP53—ulcerative colitis	8.51e-05	0.00214	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CXCR1—ulcerative colitis	8.45e-05	0.00212	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—GNA12—ulcerative colitis	8.4e-05	0.00211	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	8.3e-05	0.00208	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CCL20—ulcerative colitis	8.12e-05	0.00204	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—CXCR2—ulcerative colitis	7.97e-05	0.002	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—GHRL—ulcerative colitis	7.88e-05	0.00198	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CXCR1—ulcerative colitis	7.67e-05	0.00193	CbGpPWpGaD
Alfuzosin—KCNH2—SIDS Susceptibility Pathways—IL6—ulcerative colitis	7.64e-05	0.00192	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—GNA12—ulcerative colitis	7.63e-05	0.00192	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CXCR1—ulcerative colitis	7.5e-05	0.00188	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—CCR6—ulcerative colitis	7.49e-05	0.00188	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CCL20—ulcerative colitis	7.42e-05	0.00186	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—ADRB2—ulcerative colitis	7.34e-05	0.00184	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CXCR2—ulcerative colitis	7.23e-05	0.00182	CbGpPWpGaD
Alfuzosin—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	7.11e-05	0.00178	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—GNA12—ulcerative colitis	6.97e-05	0.00175	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	6.89e-05	0.00173	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CXCR1—ulcerative colitis	6.82e-05	0.00171	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CCR6—ulcerative colitis	6.8e-05	0.00171	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CCL20—ulcerative colitis	6.74e-05	0.00169	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SEL1L—ulcerative colitis	6.63e-05	0.00166	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CXCR2—ulcerative colitis	6.61e-05	0.00166	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PTGER4—ulcerative colitis	6.59e-05	0.00166	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CCL20—ulcerative colitis	6.59e-05	0.00165	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—ADRB2—ulcerative colitis	6.52e-05	0.00164	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—GNA12—ulcerative colitis	6.33e-05	0.00159	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CCR6—ulcerative colitis	6.22e-05	0.00156	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—GNA12—ulcerative colitis	6.19e-05	0.00156	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	6.12e-05	0.00154	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—GHRL—ulcerative colitis	6.04e-05	0.00152	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CXCR2—ulcerative colitis	6e-05	0.00151	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PTGER4—ulcerative colitis	5.99e-05	0.0015	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CCL20—ulcerative colitis	5.98e-05	0.0015	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CXCR2—ulcerative colitis	5.87e-05	0.00147	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CCR6—ulcerative colitis	5.64e-05	0.00142	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—GNA12—ulcerative colitis	5.63e-05	0.00141	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	5.61e-05	0.00141	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CCR6—ulcerative colitis	5.52e-05	0.00139	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SEL1L—ulcerative colitis	5.5e-05	0.00138	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—GHRL—ulcerative colitis	5.48e-05	0.00138	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PTGER4—ulcerative colitis	5.47e-05	0.00137	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CXCR1—ulcerative colitis	5.46e-05	0.00137	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CXCR2—ulcerative colitis	5.33e-05	0.00134	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CALM3—ulcerative colitis	5.31e-05	0.00133	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CCR6—ulcerative colitis	5.01e-05	0.00126	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—GHRL—ulcerative colitis	5.01e-05	0.00126	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—ADRB2—ulcerative colitis	5e-05	0.00125	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PTGER4—ulcerative colitis	4.97e-05	0.00125	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SEL1L—ulcerative colitis	4.89e-05	0.00123	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PTGER4—ulcerative colitis	4.86e-05	0.00122	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCL20—ulcerative colitis	4.79e-05	0.0012	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	4.65e-05	0.00117	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—GHRL—ulcerative colitis	4.55e-05	0.00114	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—ADRB2—ulcerative colitis	4.54e-05	0.00114	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CXCR1—ulcerative colitis	4.53e-05	0.00114	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—GNA12—ulcerative colitis	4.51e-05	0.00113	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—GHRL—ulcerative colitis	4.45e-05	0.00112	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PTGER4—ulcerative colitis	4.41e-05	0.00111	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CALM3—ulcerative colitis	4.41e-05	0.00111	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CXCR2—ulcerative colitis	4.27e-05	0.00107	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—CXCL8—ulcerative colitis	4.27e-05	0.00107	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	4.25e-05	0.00107	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—ADCY5—ulcerative colitis	4.24e-05	0.00106	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—ADRB2—ulcerative colitis	4.15e-05	0.00104	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	4.13e-05	0.00104	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—GHRL—ulcerative colitis	4.04e-05	0.00101	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CXCR1—ulcerative colitis	4.03e-05	0.00101	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCR6—ulcerative colitis	4.02e-05	0.00101	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCL20—ulcerative colitis	3.98e-05	0.000999	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CALM3—ulcerative colitis	3.91e-05	0.000983	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—ADCY5—ulcerative colitis	3.85e-05	0.000967	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MAML2—ulcerative colitis	3.81e-05	0.000956	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—ADRB2—ulcerative colitis	3.77e-05	0.000945	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GNA12—ulcerative colitis	3.74e-05	0.000939	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—ADRB2—ulcerative colitis	3.68e-05	0.000925	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CXCR2—ulcerative colitis	3.55e-05	0.00089	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—CXCL8—ulcerative colitis	3.54e-05	0.00089	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PTGER4—ulcerative colitis	3.54e-05	0.000888	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCL20—ulcerative colitis	3.53e-05	0.000887	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	3.53e-05	0.000886	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—ADCY5—ulcerative colitis	3.52e-05	0.000884	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—ADRB2—ulcerative colitis	3.35e-05	0.00084	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCR6—ulcerative colitis	3.33e-05	0.000837	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GNA12—ulcerative colitis	3.32e-05	0.000834	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—GHRL—ulcerative colitis	3.24e-05	0.000813	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—ADCY5—ulcerative colitis	3.2e-05	0.000802	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MAML2—ulcerative colitis	3.16e-05	0.000794	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CXCR2—ulcerative colitis	3.15e-05	0.000791	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—CXCL8—ulcerative colitis	3.15e-05	0.00079	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CALM3—ulcerative colitis	3.14e-05	0.000787	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	3.14e-05	0.000787	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—ADCY5—ulcerative colitis	3.13e-05	0.000785	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—RIPK2—ulcerative colitis	3.09e-05	0.000776	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCR6—ulcerative colitis	2.96e-05	0.000744	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PTGER4—ulcerative colitis	2.94e-05	0.000737	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CHP1—ulcerative colitis	2.91e-05	0.000731	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—ADCY5—ulcerative colitis	2.84e-05	0.000713	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MAML2—ulcerative colitis	2.81e-05	0.000705	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GHRL—ulcerative colitis	2.69e-05	0.000675	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ADRB2—ulcerative colitis	2.68e-05	0.000673	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—JAK2—ulcerative colitis	2.64e-05	0.000664	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PTGER4—ulcerative colitis	2.61e-05	0.000655	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CALM3—ulcerative colitis	2.6e-05	0.000653	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RIPK2—ulcerative colitis	2.56e-05	0.000644	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—DLD—ulcerative colitis	2.51e-05	0.000631	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—CXCL8—ulcerative colitis	2.41e-05	0.000606	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—JAK2—ulcerative colitis	2.4e-05	0.000603	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GHRL—ulcerative colitis	2.39e-05	0.000599	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CALM3—ulcerative colitis	2.31e-05	0.00058	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—IL2—ulcerative colitis	2.31e-05	0.000579	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RIPK2—ulcerative colitis	2.28e-05	0.000572	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ADCY5—ulcerative colitis	2.28e-05	0.000571	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ADRB2—ulcerative colitis	2.22e-05	0.000558	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—JAK2—ulcerative colitis	2.19e-05	0.000551	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CXCL8—ulcerative colitis	2.19e-05	0.00055	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—IL2—ulcerative colitis	2.09e-05	0.000526	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CXCL8—ulcerative colitis	2e-05	0.000503	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—JAK2—ulcerative colitis	1.99e-05	0.0005	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ADRB2—ulcerative colitis	1.98e-05	0.000496	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—JAK2—ulcerative colitis	1.95e-05	0.000489	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—IL2—ulcerative colitis	1.91e-05	0.000481	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ADCY5—ulcerative colitis	1.89e-05	0.000474	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CXCL8—ulcerative colitis	1.82e-05	0.000457	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CXCL8—ulcerative colitis	1.78e-05	0.000447	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—JAK2—ulcerative colitis	1.77e-05	0.000444	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—IL2—ulcerative colitis	1.74e-05	0.000436	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—IL2—ulcerative colitis	1.7e-05	0.000427	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ADCY5—ulcerative colitis	1.68e-05	0.000421	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CXCL8—ulcerative colitis	1.62e-05	0.000406	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IL2—ulcerative colitis	1.54e-05	0.000388	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—JAK2—ulcerative colitis	1.42e-05	0.000356	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—RELA—ulcerative colitis	1.37e-05	0.000345	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CXCL8—ulcerative colitis	1.29e-05	0.000325	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL2—ulcerative colitis	1.24e-05	0.000311	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—IL6—ulcerative colitis	1.23e-05	0.000309	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.22e-05	0.000305	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—JAK2—ulcerative colitis	1.18e-05	0.000296	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MMP9—ulcerative colitis	1.17e-05	0.000294	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NFKB1—ulcerative colitis	1.16e-05	0.000291	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RELA—ulcerative colitis	1.14e-05	0.000286	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.09e-05	0.000275	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CXCL8—ulcerative colitis	1.07e-05	0.00027	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—JAK2—ulcerative colitis	1.05e-05	0.000263	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—STAT3—ulcerative colitis	1.04e-05	0.000261	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL2—ulcerative colitis	1.03e-05	0.000258	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—IL6—ulcerative colitis	1.02e-05	0.000256	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RELA—ulcerative colitis	1.01e-05	0.000254	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MMP9—ulcerative colitis	9.72e-06	0.000244	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TGFB1—ulcerative colitis	9.65e-06	0.000242	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NFKB1—ulcerative colitis	9.62e-06	0.000241	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CXCL8—ulcerative colitis	9.54e-06	0.00024	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL2—ulcerative colitis	9.12e-06	0.000229	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IL6—ulcerative colitis	9.08e-06	0.000228	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—STAT3—ulcerative colitis	8.64e-06	0.000217	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MMP9—ulcerative colitis	8.63e-06	0.000217	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NFKB1—ulcerative colitis	8.54e-06	0.000214	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ABCB1—ulcerative colitis	8.51e-06	0.000214	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TGFB1—ulcerative colitis	8.01e-06	0.000201	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TP53—ulcerative colitis	7.95e-06	0.000199	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ADCY5—ulcerative colitis	7.94e-06	0.000199	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—STAT3—ulcerative colitis	7.68e-06	0.000193	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL6—ulcerative colitis	7.27e-06	0.000183	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TGFB1—ulcerative colitis	7.12e-06	0.000179	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TP53—ulcerative colitis	6.59e-06	0.000166	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL6—ulcerative colitis	6.04e-06	0.000152	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARG—ulcerative colitis	5.92e-06	0.000149	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TP53—ulcerative colitis	5.86e-06	0.000147	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL6—ulcerative colitis	5.36e-06	0.000135	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALB—ulcerative colitis	5.33e-06	0.000134	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS2—ulcerative colitis	4.66e-06	0.000117	CbGpPWpGaD
